Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 + Ipamorelin Blend | ≥99% | Nationwide Peptides

Research-grade CJC-1295 + Ipamorelin dual blend, ≥99% purity, HPLC-MS tested. GMP-synthesized with CoA for GH-axis research. For Research Use Only. Ships fast.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

This research blend combines:

CJC-1295 – a 29-amino-acid GHRH analog with extended half-life via albumin-binding technology

Ipamorelin – a highly selective 5-amino-acid ghrelin mimetic that triggers acute GH pulses

This blend is intended for research use only and is not for human use. It is designed for controlled laboratory investigation of GH/IGF-1 signaling pathways, combining sustained GHRH receptor engagement from CJC-1295 with pulsatile ghrelin receptor activation from Ipamorelin. For research into neuroendocrine and somatotropic axis signaling mechanisms.

Key Scientific Data

High-purity CJC-1295 DAC (≥ 98%) + Ipamorelin (≥ 98%) verified by HPLC/MS

Verified sequences: CJC-1295 (Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2) + Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2)

Lyophilized dual-vial or pre-mixed blend for maximum stability

Full Certificate of Analysis (COA) for each component and blend ratio

Manufactured in GMP-aligned, ISO-compliant facilities

Suitable for GH axis, IGF-1 signaling, and synergistic secretagogue research

Research-Referenced Attributes (Based on scientific literature; not therapeutic claims. For Research Use Only. Not for human use.)

Synergistic GH release observed in human and rodent research models when peptides are combined, as noted in published preclinical studies

Sustained IGF-1 signaling observed in preclinical models following CJC-1295 administration, with additional pulsatile activity from Ipamorelin

Minimal cortisol, prolactin, or ACTH perturbation observed in preclinical secretagogue studies — supporting a selective GH signaling profile

Studied in preclinical models in the context of body composition, bone density, lipid oxidation, and sleep physiology research

Investigated in the context of tissue repair, immune signaling, and collagen synthesis in laboratory settings

Referenced in research contexts involving sarcopenia, cachexia, and recovery biology

Why Researchers Choose This CJC-1295 + Ipamorelin Blend

Widely referenced GH-axis research blend

Exact sequence match with literature-referenced structures

Transparent analytical data: HPLC ≥98%, MS confirmation

Used in endocrinology and physiology laboratory research settings

Competitive pricing with bulk options

For Research Use Only. Not for human use.

Connected topics

Follow this recovery question